PD-L1 expression correlation with metabolic parameters of 18F FDG PET/CT in nonsmall cell lung cancer>

E. Akgün (Kirikkale, Turkey), R. Akyel (Istanbul, Turkey), A. Koç (Agri, Turkey), B. Demirkol (Istanbul, Turkey), K. Baydili (Istanbul, Turkey), P. Akin Kabalak (Ankara, Turkey), Ö. Özmen (Ankara, Turkey), S. Batur (Istanbul, Turkey), A. Büge Öz (Istanbul, Turkey), Ü. Yilmaz (Ankara, Turkey), F. Demirag (Ankara, Turkey), N. Akyürek (Ankara, Turkey), E. Çetinkaya (Istanbul, Turkey)

Source: Virtual Congress 2021 – Pulmonary neoplasia and related pathologies
Session: Pulmonary neoplasia and related pathologies
Session type: E-poster
Number: 1870

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Akgün (Kirikkale, Turkey), R. Akyel (Istanbul, Turkey), A. Koç (Agri, Turkey), B. Demirkol (Istanbul, Turkey), K. Baydili (Istanbul, Turkey), P. Akin Kabalak (Ankara, Turkey), Ö. Özmen (Ankara, Turkey), S. Batur (Istanbul, Turkey), A. Büge Öz (Istanbul, Turkey), Ü. Yilmaz (Ankara, Turkey), F. Demirag (Ankara, Turkey), N. Akyürek (Ankara, Turkey), E. Çetinkaya (Istanbul, Turkey). PD-L1 expression correlation with metabolic parameters of 18F FDG PET/CT in nonsmall cell lung cancer>. 1870

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prognostic impact of FDG-PET in recurrence of surgically treated non-small cell lung cancer
Source: Annual Congress 2005 - Management of lung cancer: clinical problems
Year: 2005


Integrated 18F – FDG PET dynamic contrast enhanced CT to phenotype non-small cell lung cancer
Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients
Year: 2011


Prognostic value of primary tumour maximum standardized uptake value (SUV max) in non small cell lung cancer (NSCLC) with F18-fluorodeoxyglucose positron emission tomography (FDG-PET): a systematic review and meta-analysis (MA) by the European Lung Cancer
Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology
Year: 2007



Correlatin between PET scan and cytokine in non-small cell lung cancer (NSCLC)
Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer
Year: 2012


The importance of positron emission tomography/computed tomography (PET-CT) to identify distant metastasis in non-small cell lung cancer (NSCLC)
Source: Annual Congress 2010 - Staging of lung cancer
Year: 2010


Preoperative evaluation of locally advanced non-small cell lung cancer after induction therapy by positron emission tomography with F-18-fluorodeoxyglucose (FDG-PET)
Source: Eur Respir J 2004; 24: Suppl. 48, 457s
Year: 2004

Correlation between standardised uptake value on PET scans, tumour characteristics and survival in resected lung cancer patients
Source: Annual Congress 2007 - Prognosis and diagnosis of thoracic malignancies
Year: 2007


FDG-PET SUVmax is an independent prognostic indicator in patients with non-small cell lung cancer
Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients
Year: 2011


PET/CT of lung cancer
Source: International Congress 2018 – PG4 Imaging of the chest
Year: 2018


Prognostic value of fluorine-18 fluorodeoxyglucose (18-FDG) positron emission tomography imaging in patients with non-small cell lung carcinoma
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012

Comparision of FDG PET/CT and bone scanning for bone metastases in operable non-small cell lung cancer
Source: Annual Congress 2009 - Management of thoracic malignancies
Year: 2009

The role of positron emission tomography scan in the preoperative staging of nonsmall cell lung cancer
Source: Annual Congress 2008 - Diagnostic and therapeutic problems in thoracic surgery
Year: 2008

Synchronous primary malignancies identified during staging 18F-FDG PET scan in lung cancer patients
Source: Annual Congress 2010 - Staging of lung cancer
Year: 2010


The relation of fluorine-18 fluorodeoxyglucose positron emission tomography imaging to chemosensitivity for platinum doublet chemotherapy in patients with advanced stage non small cell lung cancer
Source: Annual Congress 2009 - Diagnosis and treatment of lung cancer
Year: 2009



Staging of non-small-cell lung cancer with FDG-PET/CT: Is there a correlation of morphologic tumor characteristics and metabolic activity?
Source: Annual Congress 2012 - Functional imaging in pulmonary oncology and COPD. Radiation dose in chest CT: survey and real life
Year: 2012


Prognostic value of integrated FDG-PET/CT in non-small cell lung cancer
Source: Annual Congress 2008 - New imaging techniques in chest imaging
Year: 2008

The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology
Source: Eur Respir J 2001; 17: 802-820
Year: 2001



PET scanning poorly predicts response to pre-operative chemotherapy in non-small cell lung cancer
Source: ISSN=ISSN 1810-6838, ISBN=, page=54
Year: 2004

Value of positron emission tomography parameters for the prognosis of small-cell lung carcinoma
Source: International Congress 2019 – Biology and prognosis of lung cancer
Year: 2019

Preoperative FDG uptake on PET/CT predicts disease recurrence and survival in early stage non-small cell lung cancer (NSCLC)
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016